Working… Menu

Study of Hydroxychloroquine and Aldesleukin in Renal Cell Carcinoma Patients (RCC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01550367
Recruitment Status : Active, not recruiting
First Posted : March 12, 2012
Last Update Posted : August 17, 2018
Prometheus Laboratories
Information provided by (Responsible Party):
Leonard Appleman, University of Pittsburgh

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : February 6, 2018
Estimated Study Completion Date : September 2018
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 July 17, 2019
August 6, 2019
2 September 3, 2019